Drug Type Small molecule drug |
Synonyms S-3 (Zhenxing Medical), ZXP 1301, ZXP1301 |
Target |
Action inhibitors |
Mechanism STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | China | 01 Sep 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | China | 01 Sep 2025 | |
| Hematologic Neoplasms | Preclinical | China | 28 Nov 2023 | |
| Pancreatic Cancer | Preclinical | China | 28 Nov 2023 |





